SEC Filing Summary: Bellevue Life Sciences Acquisition Corp. (BLAC)
Business Context and Reporting Period
This Form 8-K was filed on October 28, 2024, reporting events occurring on October 25, 2024. The registrant, Bellevue Life Sciences Acquisition Corp. (BLAC), is a Special Purpose Acquisition Company (SPAC) engaged in a proposed business combination with OSR Holdings Co., Ltd. ("OSR Holdings"). The filing details a new material definitive agreement entered into to support OSR Holdings during the pre-combination phase.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data for either BLAC or OSR Holdings. The only specific financial metric disclosed is the terms of a new loan:
- Loan Amount: $300,000 advanced by BLAC to OSR Holdings.
- Interest Rate: 3.96% per annum, compounded semi-annually.
- Maturity Date: October 25, 2025.
- Interest Payment: Payable only on maturity.
- Use of Proceeds: Working capital and other expenses for OSR Holdings.
Material Changes
The primary material change is the entry into a promissory note agreement between BLAC and OSR Holdings. This represents a new liability for OSR Holdings and a new asset for BLAC. The filing notes that a Registration Statement on Form S-4 has been filed with the SEC regarding the proposed business combination, indicating progress in the merger process.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the proposed business combination but does not provide specific financial guidance or revenue projections. Management highlights significant risks and uncertainties, including:
- Failure to obtain stockholder approval or satisfy closing conditions.
- Potential termination of the definitive agreement.
- Impact of global health disruptions (e.g., COVID-19) on operations and the combination.
- Risk of unsolicited offers interfering with the transaction.
- Disruption to OSR Holdings' current plans and operations.
- Challenges in maintaining Nasdaq listing post-combination.
- Ability to raise additional capital and retain key employees.
Investors are urged to read the preliminary and definitive proxy statements for detailed information on the business combination.
Investor Verification Checklist
- Verify the status of the Form S-4 Registration Statement and the upcoming special meeting of stockholders.
- Review the full text of the OSR Holdings Promissory Note (Exhibit 10.1) for additional covenants or default triggers.
- Confirm the record date for the stockholder vote on the business combination.
- Assess OSR Holdings' current liquidity position given the reliance on this $300,000 bridge loan.
- Monitor for any updates regarding the satisfaction of closing conditions for the merger.